[Autotransplants in leukemia: current status and perspectives].

Area of Science:

• Hematology
• Oncology
• Immunology

Context:

• Autotransplants in leukemia treatment are debated, with questions surrounding their efficacy and rationale.
• Existing data on intensive therapy and autotransplant outcomes require critical evaluation.

Purpose:

• To critically assess the evidence supporting autotransplants in leukemia treatment.
• To address specific controversies including treatment intensity, biases, relapse origins, stem cell sources, immune mechanisms, and alternative therapies.

Summary:

• Investigates whether intensive therapy improves leukemia cures.
• Examines biases in autotransplant studies, including subject selection and time-to-treatment censoring.
• Differentiates relapse origins (patient vs. graft) and evaluates outcomes based on hemopoietic stem cell sources.
• Assesses the role of immune-mediated anti-leukemia effects and the feasibility of non-transplant intensive therapies.

Impact:

• Provides a critical analysis to inform the ongoing debate on autotransplant utility in leukemia.
• Highlights areas needing further research to clarify the role of autotransplants and optimize leukemia treatment strategies.